In the last trading session, 2.44 million shares of the Vaxart Inc (NASDAQ:VXRT) were traded, and its beta was 1.43. Most recently the company’s share price was $0.52, and it changed around -$0.05 or -9.09% from the last close, which brings the market valuation of the company to $117.64M. VXRT currently trades at a discount to its 52-week high of $1.41, offering almost -171.15% off that amount. The share price’s 52-week low was $0.45, which indicates that the current value has risen by an impressive 13.46% since then. We note from Vaxart Inc’s average daily trading volume that its 10-day average is 1.65 million shares, with the 3-month average coming to 2.01 million.
Vaxart Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended VXRT as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Vaxart Inc is expected to report earnings per share of -0.09 for the current quarter.
Vaxart Inc (NASDAQ:VXRT) trade information
Instantly VXRT has showed a red trend with a performance of -9.09% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5978 on recent trading dayincreased the stock’s daily price by 13.01%. The company’s shares are currently down -22.05% year-to-date, but still down -4.27% over the last five days. On the other hand, Vaxart Inc (NASDAQ:VXRT) is -26.79% down in the 30-day period. We can see from the shorts that 13.28 million shares have been sold at a short interest cover period of 7.1 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 74.0% from its current value. Analyst projections state that VXRT is forecast to be at a low of $2 and a high of $2.
Vaxart Inc (VXRT) estimates and forecasts
The year-over-year growth rate is expected to be -82.23%, down from the previous year.
The company’s sales for the same quarters a year ago were 2.18M and 6.4M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -100.00%. Forecasts for the next quarter put sales growth at -100.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.46%. Vaxart Inc earnings are expected to increase by -1.52% in 2025, but the outlook is negative -12.51% per year for the next five years.
VXRT Dividends
Vaxart Inc’s next quarterly earnings report is expected to be released on 2025-Mar-19.
Vaxart Inc (NASDAQ:VXRT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.77% of Vaxart Inc shares, and 15.81% of them are in the hands of institutional investors. The stock currently has a share float of 15.93%. Vaxart Inc stock is held by 109.0 institutions, with SIO CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 7.9939% of the shares, which is about 14.76 million shares worth $9.85 million.
VANGUARD GROUP INC, with 5.3875% or 9.95 million shares worth $6.64 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 7.16 shares worth $3.69 million, making up 3.15% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 2.52 shares worth around $1.3 million, which represents about 1.11% of the total shares outstanding.
